In db/db and STZ-treated diabetic nephropathy mice, miR-10a/b curbs NLRP3 inflammasome activation, reducing pro-inflammatory cytokines IL-1β and IL-This notably improves renal inflammation and alleviates albuminuria. Here, NLRP3 is linked to diabetic kidney disease.